Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Research & Development: 2018-2024

Historic Research & Development for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to $303.6 million.

  • Avidity Biosciences' Research & Development rose 100.72% to $154.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.2 million, marking a year-over-year increase of 87.20%. This contributed to the annual value of $303.6 million for FY2024, which is 58.98% up from last year.
  • According to the latest figures from FY2024, Avidity Biosciences' Research & Development is $303.6 million, which was up 58.98% from $191.0 million recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Research & Development ranged from a high of $303.6 million in FY2024 and a low of $37.6 million during FY2020.
  • Its 3-year average for Research & Development is $215.0 million, with a median of $191.0 million in 2023.
  • Data for Avidity Biosciences' Research & Development shows a peak YoY surged of 169.09% (in 2021) over the last 5 years.
  • Over the past 5 years, Avidity Biosciences' Research & Development (Yearly) stood at $37.6 million in 2020, then surged by 169.09% to $101.2 million in 2021, then spiked by 48.65% to $150.4 million in 2022, then rose by 26.97% to $191.0 million in 2023, then soared by 58.98% to $303.6 million in 2024.